These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24953695)

  • 1. Ethanol affects hepatitis C pathogenesis: humanized SCID Alb-uPA mouse model.
    Osna NA; Kharbanda KK; Sun Y; Simpson RL; Poluektova LE; Ganesan M; Wisecarver JL; Mercer DF
    Biochem Biophys Res Commun; 2014 Jul; 450(1):773-6. PubMed ID: 24953695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
    Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice.
    Joyce MA; Walters KA; Lamb SE; Yeh MM; Zhu LF; Kneteman N; Doyle JS; Katze MG; Tyrrell DL
    PLoS Pathog; 2009 Feb; 5(2):e1000291. PubMed ID: 19242562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cDNA-uPA/SCID/Rag2
    Uchida T; Teraoka Y; Imamura M; Abe-Chayama H; Makokha GN; Hayes CN; Aikata H; Hamamura S; Ishida Y; Tateno C; Shirouzu T; Kawai S; Tanaka Y; Ohdan H; Okada S; Chayama K
    J Viral Hepat; 2023 Mar; 30(3):262-272. PubMed ID: 36575861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
    Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
    J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application.
    Kneteman NM; Weiner AJ; O'Connell J; Collett M; Gao T; Aukerman L; Kovelsky R; Ni ZJ; Zhu Q; Hashash A; Kline J; Hsi B; Schiller D; Douglas D; Tyrrell DL; Mercer DF
    Hepatology; 2006 Jun; 43(6):1346-53. PubMed ID: 16729319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric mouse model for the infection of hepatitis B and C viruses.
    Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
    PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Novel Chimeric Mice with Humanized Livers by Using Hemizygous cDNA-uPA/SCID Mice.
    Tateno C; Kawase Y; Tobita Y; Hamamura S; Ohshita H; Yokomichi H; Sanada H; Kakuni M; Shiota A; Kojima Y; Ishida Y; Shitara H; Wada NA; Tateishi H; Sudoh M; Nagatsuka S; Jishage K; Kohara M
    PLoS One; 2015; 10(11):e0142145. PubMed ID: 26536627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol and hepatitis C virus suppress peptide-MHC class I presentation in hepatocytes by altering proteasome function.
    Osna NA; Bardag-Gorce F; White RL; Weinman SA; Donohue TM; Kharbanda KK
    Alcohol Clin Exp Res; 2012 Dec; 36(12):2028-35. PubMed ID: 22551112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of humanized mice for the study of hepatitis C virus infection.
    Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
    Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy.
    DebRoy S; Hiraga N; Imamura M; Hayes CN; Akamatsu S; Canini L; Perelson AS; Pohl RT; Persiani S; Uprichard SL; Tateno C; Dahari H; Chayama K
    J Viral Hepat; 2016 Sep; 23(9):708-17. PubMed ID: 27272497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
    Ohshita H; Tateno C
    Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
    Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ethanol consumption on experimental viral hepatitis.
    Jerrells TR; Mitchell K; Pavlik J; Jerrells J; Hoerman D
    Alcohol Clin Exp Res; 2002 Nov; 26(11):1734-46. PubMed ID: 12436064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-specific response to HCV infection in the chimeric SCID-beige/Alb-uPA mouse model: role of the innate antiviral immune response.
    Walters KA; Joyce MA; Thompson JC; Smith MW; Yeh MM; Proll S; Zhu LF; Gao TJ; Kneteman NM; Tyrrell DL; Katze MG
    PLoS Pathog; 2006 Jun; 2(6):e59. PubMed ID: 16789836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
    Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
    Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
    Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
    J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.
    Kamiya N; Iwao E; Hiraga N; Tsuge M; Imamura M; Takahashi S; Miyoshi S; Tateno C; Yoshizato K; Chayama K
    J Gen Virol; 2010 Jul; 91(Pt 7):1668-77. PubMed ID: 20164258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
    Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
    Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.